PEPS
MCID: EPL050
MIFTS: 26

Epilepsy, Partial, with Pericentral Spikes (PEPS)

Aliases & Classifications for Epilepsy, Partial, with Pericentral Spikes

MalaCards integrated aliases for Epilepsy, Partial, with Pericentral Spikes:

Name: Epilepsy, Partial, with Pericentral Spikes 57 13 72
Peps 57
Epps 57

External Ids:

OMIM 57 607221
UMLS 72 C1846609

Summaries for Epilepsy, Partial, with Pericentral Spikes

MalaCards based summary : Epilepsy, Partial, with Pericentral Spikes, also known as peps, is related to protoporphyria, erythropoietic, 1 and poems syndrome. An important gene associated with Epilepsy, Partial, with Pericentral Spikes is EPPS (Epilepsy, Partial, With Pericentral Spikes). The drugs Pemetrexed and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include testes, breast and brain.

More information from OMIM: 607221

Related Diseases for Epilepsy, Partial, with Pericentral Spikes

Diseases related to Epilepsy, Partial, with Pericentral Spikes via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 136)
# Related Disease Score Top Affiliating Genes
1 protoporphyria, erythropoietic, 1 12.4
2 poems syndrome 11.9
3 pruritic urticarial papules and plaques of pregnancy 11.3
4 pepck 1 deficiency 11.2
5 protoporphyria, erythropoietic, 2 11.2
6 porphyria 11.2
7 cutaneous porphyria 11.2
8 cystic fibrosis 10.4
9 pulmonary embolism 10.4
10 rabies 10.3
11 benign mesothelioma 10.2
12 malignant pleural mesothelioma 10.2
13 chlamydia pneumonia 10.2
14 chlamydia 10.2
15 cerebrovascular disease 10.2
16 hypertriglyceridemia, familial 10.2
17 pulmonary disease, chronic obstructive 10.2
18 bronchitis 10.2
19 neutropenia 10.1
20 personality disorder 10.1
21 vascular disease 10.1
22 transient cerebral ischemia 10.1
23 idiopathic interstitial pneumonia 10.1
24 pulmonary fibrosis 10.1
25 liver disease 10.1
26 myasthenia gravis 10.1
27 polycystic kidney disease 10.1
28 acute cystitis 10.1
29 candidiasis 10.1
30 angioedema 10.1
31 vulvovaginal candidiasis 10.1
32 iron metabolism disease 10.1
33 urinary tract obstruction 10.1
34 pneumonia 10.1
35 kidney disease 10.1
36 48,xyyy 10.1
37 brain injury 10.1
38 traumatic brain injury 10.1
39 tremor 10.1
40 autoimmune disease 10.0
41 fibrosis of extraocular muscles, congenital, 1 10.0
42 attention deficit-hyperactivity disorder 10.0
43 paroxysmal extreme pain disorder 10.0
44 autism 10.0
45 anxiety 10.0
46 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
47 gastric cancer 10.0
48 mantle cell lymphoma 10.0
49 tetanus 10.0
50 heart disease 10.0

Graphical network of the top 20 diseases related to Epilepsy, Partial, with Pericentral Spikes:



Diseases related to Epilepsy, Partial, with Pericentral Spikes

Symptoms & Phenotypes for Epilepsy, Partial, with Pericentral Spikes

Clinical features from OMIM:

607221

Drugs & Therapeutics for Epilepsy, Partial, with Pericentral Spikes

Drugs for Epilepsy, Partial, with Pericentral Spikes (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pemetrexed Approved, Investigational Phase 1 150399-23-8, 137281-23-3 60843 446556
2
Cisplatin Approved Phase 1 15663-27-1 84093 441203 2767
3
leucovorin Approved Phase 1 58-05-9 143 6006
4
Folic acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
5 Folic Acid Antagonists Phase 1
6 Nucleic Acid Synthesis Inhibitors Phase 1
7 Vitamin B9 Phase 1
8 Folate Phase 1
9 Vitamin B Complex Phase 1
10 Antipsychotic Agents
11 Fibrin fragment D
12 Hemostatics
13 Coagulants
14 Antifibrinolytic Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis Withdrawn NCT01573806 Phase 1, Phase 2 Exenatide;Exenatide vehicle
2 Phase I Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas Recruiting NCT02838745 Phase 1 Pemetrexed;Cisplatin
3 Positive Emotions Program for Schizophrenia (PEPS): A Randomized Controlled Study on Improving Pleasure and Motivation in Schizophrenia Completed NCT02593058
4 Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy Completed NCT02300675
5 Proyecto ESCUDO: Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users Completed NCT02444403
6 Prevention of Peritonitis in Patients With Peritoneal Dialysis - Effects of Regular Follow-up of Patients´ Theoretical Knowledge and Practical Skills With Focus on Infection Prophylaxis Completed NCT01293799
7 MOdified DIagnostic strateGy to Safely ruLe-out Pulmonary Embolism In the Emergency depArtment: A Non-Inferiority Cluster Cross-over Randomized Trial Not yet recruiting NCT04032769

Search NIH Clinical Center for Epilepsy, Partial, with Pericentral Spikes

Genetic Tests for Epilepsy, Partial, with Pericentral Spikes

Anatomical Context for Epilepsy, Partial, with Pericentral Spikes

MalaCards organs/tissues related to Epilepsy, Partial, with Pericentral Spikes:

41
Testes, Breast, Brain, Lung, Eye, Heart, Skin

Publications for Epilepsy, Partial, with Pericentral Spikes

Articles related to Epilepsy, Partial, with Pericentral Spikes:

(show top 50) (show all 280)
# Title Authors PMID Year
1
Partial epilepsy with pericentral spikes: a new familial epilepsy syndrome with evidence for linkage to chromosome 4p15. 8
12112080 2002
2
Danger-Associated Peptides Interact with PIN-Dependent Local Auxin Distribution to Inhibit Root Growth in Arabidopsis. 38
31123046 2019
3
Cleave and Unleash: Metacaspases Prepare Peps for Work. 38
31272898 2019
4
One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry. 38
31103407 2019
5
A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures. 38
31230646 2019
6
Pinprick Evoked Potentials-Reliable Acquisition in Healthy Human Volunteers. 38
31216028 2019
7
An intramembrane sensory circuit monitors sortase A-mediated processing of streptococcal adhesins. 38
31064885 2019
8
Central sensitization increases the pupil dilation elicited by mechanical pinprick stimulation. 38
30785805 2019
9
Rapid, label-free genetic detection of enteropathogens in stool without genetic isolation or amplification. 38
30731348 2019
10
The Carbon Switch at the Level of Pyruvate and Phosphoenolpyruvate in Sulfolobus solfataricus P2. 38
31031731 2019
11
Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test. 38
31404331 2019
12
Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial. 38
30783071 2019
13
Improving police conceptual knowledge of Mexico's law on cannabis possession: Findings from an assessment of a police education program. 38
30516331 2018
14
A novel and sensitive chemiluminescence immunoassay based on AuNCs@pepsin@luminol for simultaneous detection of tetrabromobisphenol A bis(2-hydroxyethyl) ether and tetrabromobisphenol A mono(hydroxyethyl) ether. 38
30224136 2018
15
Nonlinear Emission of Molecular Ensembles Strongly Coupled to Plasmonic Lattices with Structural Imperfections. 38
30608720 2018
16
In situ, amplification-free double-stranded mutation detection at 60 copies/ml with thousand-fold wild type in urine. 38
30142581 2018
17
Influence of physician evaluation portals on orthodontist selection by patients. 38
30187082 2018
18
The feasibility and appropriateness of a peer-to-peer, play-based intervention for improving pragmatic language in children with autism spectrum disorder. 38
30175619 2018
19
Improvements in the water dispersibility of paclitaxel by complexing with synthetic peptides derived from β-casein. 38
29635137 2018
20
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. 38
29767567 2018
21
The plant cell wall integrity maintenance and immune signaling systems cooperate to control stress responses in Arabidopsis thaliana. 38
29945884 2018
22
Integration of danger peptide signals with herbivore-associated molecular pattern signaling amplifies anti-herbivore defense responses in rice. 38
29513388 2018
23
Danger-Associated Peptides Close Stomata by OST1-Independent Activation of Anion Channels in Guard Cells. 38
29716993 2018
24
Differential effect of a patient-education transition intervention in adolescents with IBD vs. diabetes. 38
29340756 2018
25
Plant elicitor peptides promote plant defences against nematodes in soybean. 38
28600875 2018
26
β-Lactoglobulin Peptide Fragments Conjugated with Caffeic Acid Displaying Dual Activities for Tyrosinase Inhibition and Antioxidant Effect. 38
29533643 2018
27
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. 38
28663026 2018
28
The physical education predisposition scale: Preliminary tests of reliability and validity in Australian students. 38
28357932 2018
29
Novel Rosaceae plant elicitor peptides as sustainable tools to control Xanthomonas arboricola pv. pruni in Prunus spp. 38
28056495 2018
30
Diversity of plant defense elicitor peptides within the Rosaceae. 38
29361905 2018
31
Executive Functions and Prosodic Abilities in Children With High-Functioning Autism. 38
29618997 2018
32
Structural Characterization of Polysaccharides of a Productive Strain of the Culinary-Medicinal King Oyster Mushroom, Pleurotus eryngii (Agaricomycetes), from Italy. 38
30317948 2018
33
An innovative way to highlight the power of each polymorphism on elite athletes phenotype expression. 38
29686814 2018
34
Perturbation-evoked potentials: Significance and application in balance control research. 38
29107828 2017
35
Psychoeducation and Problem Solving (PEPS) Therapy for Adults With Personality Disorder: A Pragmatic Randomized-Controlled Trial. 38
28513346 2017
36
Synergistic effects of engineered nanoparticles and organics released from laser printers using nano-enabled toners: potential health implications from exposures to the emitted organic aerosol. 38
30197786 2017
37
Modelling gene-environment interaction in first episodes of psychosis. 38
28179063 2017
38
Comparison of perceptual eye positions among patients with different degrees of anisometropia. 38
28953639 2017
39
Relationship between pemphigus and American tegumentary leishmaniasis: insights from serological and genetic profiles. 38
29237064 2017
40
Phase-locked and non-phase-locked EEG responses to pinprick stimulation before and after experimentally-induced secondary hyperalgesia. 38
28618295 2017
41
Sulphonated modification of polysaccharides from Pleurotus eryngii and Streptococcus thermophilus ASCC 1275 and antioxidant activities investigation using CCD and Caco-2 cell line models. 38
28193422 2017
42
Adherence to Analgesics in Oncology Outpatients: Focus on Taking Analgesics on Time. 38
27739244 2017
43
Immune responses induced by oligogalacturonides are differentially affected by AvrPto and loss of BAK1/BKK1 and PEPR1/PEPR2. 38
27118426 2017
44
Prosody Perception and Production in Children with Hearing Loss and Age- and Gender-Matched Controls. 38
28418324 2017
45
Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes. 38
28292959 2017
46
Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study. 38
28196066 2017
47
Effectiveness of a psychoeducation program on the quality of life in patients with coronary heart disease: A clinical trial. 38
28096020 2017
48
The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate. 38
27581118 2017
49
A Century Spent Combating Rabies in Morocco (1911-2015): How Much Longer? 38
28626749 2017
50
Self-Reported Reasons for Smoking: Predicting Abstinence and Implications for Smoking Cessation Treatments Among Those With a Psychotic Disorder. 38
27982748 2017

Variations for Epilepsy, Partial, with Pericentral Spikes

Expression for Epilepsy, Partial, with Pericentral Spikes

Search GEO for disease gene expression data for Epilepsy, Partial, with Pericentral Spikes.

Pathways for Epilepsy, Partial, with Pericentral Spikes

GO Terms for Epilepsy, Partial, with Pericentral Spikes

Sources for Epilepsy, Partial, with Pericentral Spikes

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....